Capital Impact Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-21,537
| Closed | -$572K | – | 192 |
|
2021
Q4 | $572K | Sell |
21,537
-2,224
| -9% | -$59.1K | 0.39% | 78 |
|
2021
Q3 | $976K | Sell |
23,761
-7,719
| -25% | -$317K | 0.39% | 101 |
|
2021
Q2 | $1.78M | Buy |
31,480
+22,515
| +251% | +$1.28M | 0.58% | 76 |
|
2021
Q1 | $377K | Sell |
8,965
-121,035
| -93% | -$5.09M | 0.13% | 101 |
|
2020
Q4 | $9.11M | Buy |
130,000
+105,000
| +420% | +$7.36M | 2.24% | 6 |
|
2020
Q3 | $702K | Buy |
+25,000
| New | +$702K | 0.21% | 105 |
|
2019
Q2 | – | Sell |
-63,637
| Closed | -$1.32M | – | 128 |
|
2019
Q1 | $1.32M | Hold |
63,637
| – | – | 0.58% | 100 |
|
2018
Q4 | $1.32M | Buy |
63,637
+6,231
| +11% | +$129K | 0.56% | 103 |
|
2018
Q3 | $1.86M | Buy |
57,406
+10,138
| +21% | +$329K | 0.64% | 77 |
|
2018
Q2 | $1.7M | Buy |
47,268
+6,170
| +15% | +$221K | 0.63% | 92 |
|
2018
Q1 | $1.36M | Buy |
+41,098
| New | +$1.36M | 0.56% | 94 |
|